Charge deficient analogues of the natural polyamines

Current Pharmaceutical Design

Volumn 20, Issue 2, 2014, Pages 262-277

  Weisell, Janne ^a   Hyvönen, Mervi T ^b   Alhonen, Leena ^a   Vepsäläinen, Jouko ^a   Keinänen, Tuomo A ^a,b   Khomutov, Alex R ^c  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

Author keywords

Cell organelles; Charge deficient; Ornithine decarboxylase; Polyamine; Polyamine analog; Reactive oxygen species

Indexed keywords

ACYLTRANSFERASE; AMINE; CARBON; FLUORINE; HYDROGEN; HYDROGEN PEROXIDE; HYDROXYLAMINE; METHYLAMINE; POLYAMINE; PUTRESCINE; REACTIVE OXYGEN METABOLITE; SPERMIDINE; SPERMINE;

ACETYLATION; ANIMAL CELL; ANIMAL TISSUE; ATOM; BIOGENESIS; BIOSYNTHESIS; CELL DAMAGE; CELL DEATH; CELL DIFFERENTIATION; CELL ENERGY; CELL PROLIFERATION; IMMUNE RESPONSE; INFLAMMATION; MITOCHONDRION; MOUSE; NONHUMAN; POLYAMINE METABOLISM; PRIORITY JOURNAL; RAT; REVIEW;

ACETYLTRANSFERASES; ANIMALS; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; POLYAMINES; REACTIVE OXYGEN SPECIES; SPERMIDINE; SPERMINE;

EID: 84892956577     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/13816128113199990037     Document Type: Review

References (234)

1. Park H, Bourla AB, Kastner DL, Colbert RA, Siegel RM. Lighting the fires within: the cell biology of autoinflammatory diseases. Nat Rev Immunol 2012; 12: 570-80.
2. Miriyala S, Holley AK, St Clair DK. Mitochondrial superoxide dismutase-signals of distinction. Anticancer Agents Med Chem 2011; 11: 181-90.
3. Salinas GF, Braza F, Brouard S, Tak PP, Baeten D. The role of B lymphocytes in the progression from autoimmunity to autoimmune disease. Clin Immunol 2012; 146: 34-45.
4. Lokmic Z, Musyoka J, Hewitson TD, Darby IA. Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int Rev Cell Mol Biol 2012; 296: 139-85.
5. Tarin D. Cell and tissue interactions in carcinogenesis and metastasis and their clinical significance. Semin Cancer Biol 2011; 21: 72-82.
6. Tait SW, Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol 2010; 11: 621-32.
7. Monian P, Jiang X. Clearing the final hurdles to mitochondrial apoptosis: regulation post cytochrome C release. Exp Oncol 2012; 34: 185-91.
8. Toninello A, Pietrangeli P, De Marchi U, Salvi M, Mondovi B. Amine oxidases in apoptosis and cancer. Biochim Biophys Acta 2006; 1765: 1-13.
9. Ouyang L, Shi Z, Zhao S, et al. Programmed cell death pathways in cancer: a review of apoptosis, autophagy and programmed necrosis. Cell Prolif 2012; 45: 487-98.
10. Sun Y, Peng ZL. Programmed cell death and cancer. Postgrad Med J 2009; 85: 134-40.
11. Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell 2008; 132: 27-42.
12. Youle RJ, van der Bliek AM. Mitochondrial fission, fusion, and stress. Science 2012; 337: 1062-5.
13. Michel S, Wanet A, De Pauw A, et al. Crosstalk between mitochondrial (dys)function and mitochondrial abundance. J Cell Physiol 2012; 227: 2297-310.
14. Cline SD. Mitochondrial DNA damage and its consequences for mitochondrial gene expression. Biochim Biophys Acta 2012; 1819: 979-91.
15. Shadel GS. Expression and maintenance of mitochondrial DNA: new insights into human disease pathology. Am J Pathol 2008; 172: 1445-56.
16. Dikalov S. Cross talk between mitochondria and NADPH oxidases. Free Radic Biol Med 2011; 51: 1289-301.
17. Ozden O, Park SH, Kim HS, et al. Acetylation of MnSOD directs enzymatic activity responding to cellular nutrient status or oxidative stress. Aging (Albany NY) 2011; 3: 102-7.
18. Edeas M, Attaf D, Mailfert AS, Nasu M, Joubet R. Maillard reaction, mitochondria and oxidative stress: potential role of antioxidants. Pathol Biol (Paris) 2010; 58: 220-5.
19. Buettner GR. Superoxide dismutase in redox biology: the roles of superoxide and hydrogen peroxide. Anticancer Agents Med Chem 2011; 11: 341-6.
20. Pegg AE. Mammalian polyamine metabolism and function. IUBMB Life 2009; 61: 880-94.
21. Casero RA, Pegg AE. Polyamine catabolism and disease. Biochem J 2009; 421: 323-38.
22. Pegg AE, Feith DJ. Polyamines and neoplastic growth. Biochem Soc Trans 2007; 35: 295-9.
23. Jänne J, Alhonen L, Keinänen TA, et al. Animal disease models generated by genetic engineering of polyamine metabolism. J Cell Mol Med 2005; 9: 865-82.
24. Tabor CW, Tabor H. Polyamines. Ann Rev Biochem 1984; 53: 749-90.
25. Isomaa VV, Pajunen AEI, Bardin CW, Jänne OA. Ornithine decarboxylase in mouse kidney. J Biol Chem 1983; 258: 6735-40.
26. Seely JE, Pösö H, Pegg AE. Effect of androgens in turnover of ornithine decarboxylase in mouse kidney. Studies using labeling of the enzyme by reaction with (14C)alpha-difluoromethylornithine. J Biol Chem 1982; 257: 7549-53.
27. Hannonen P, Raina A, Jänne J. Polyamine synthesis in the regenerating rat liver: stimulation of S-adenosylmethionine decarboxylase, and spermidine and spermine synthases after partial hepatectomy. Biochim Biophys Acta 1972; 273: 84-90.
28. Pegg AE. Investigation of the turnover of rat liver Sadenosylmethionine decarboxylase using a specific antibody. J Biol Chem 1979; 254: 3249-53.
29. Shirahata A, Pegg AE. Regulation of S-adenosylmethionine decarboxylase activity in rat liver and prostate. J Biol Chem 1985; 260: 9583-8.
30. Pegg AE. Regulation of ornithine decarboxylase. J Biol Chem 2006; 281: 14529-32.
31. Pegg AE. S-Adenosylmethionine decarboxylase. Essays Biochem 2009; 46: 25-45.
32. Kahana C. Regulation of cellular polyamine levels and cellular proliferation by antizyme and antizyme inhibitor. Essays Biochem 2009; 46: 47-61.
33. Suzuki T, He Y, Kashiwagi K, et al. Antizyme protects against abnormal accumulation and toxicity of polyamines in ornithine decarboxylase-overproducing cells. Proc Natl Acad Sci USA 1994; 91: 8930-4.
34. Mitchell JLA, Judd GG, Bareyal-Leyser A, Ling SY. Feedback repression of polyamine transport is mediated by antizyme in mammalian tissue-culture cells. Biochem J 1994; 299: 19-22.
35. Petros LM, Howard MT, Gesteland RF, Atkins JF. Polyamine sensing during antizyme mRNA programmed frameshifting. Biochem Biophys Res Commun 2005; 338: 1478-89.
36. Matsufuji S, Matsufuji T, Miyazaki Y, et al. Autoregulatory frameshifting in decoding mammalian ornithine decarboxylase antizyme. Cell 1995; 80: 51-60.
37. Kahana C. Antizyme and antizyme inhibitor, a regulatory tango. Cell Mol Life Sci 2009; 66: 2479-88.
38. Hill JR, Morris DR. Cell-specific translational regulation of Sadenosylmethionine decarboxylase mRNA. Dependence on translation and codin capacity of the cis-acting upstream open reading frame. J Biol Chem 1993; 268: 726-31.
39. Ruan H, Shantz LM, Pegg AE, Morris DR. The upstream open reading frame of the mRNA encoding S-adenosylmethionine decarboxylase is a polyamine-responsive translational control element. J Biol Chem 1996; 271: 29576-82.
40. Pegg AE. Spermidine/spermine-N(1)-acetyltransferase: a key metabolic regulator. Am J Physiol Endocrinol Metab 2008; 294: E995-1010.
41. Montemayor EJ, Hoffman DW. The crystal structure of spermidine/spermine N1-acetyltransferase in complex with spermine provides insights into substrate binding and catalysis. Biochemistry 2008; 47: 9145-53.
42. Hegde SS, Chandler J, Vetting MW, Yu M, Blanchard JS. Mechanistic and structural analysis of human spermidine/spermine N1-acetyltransferase. Biochemistry 2007; 46: 7187-95.
43. Persson L, Pegg AE. Studies of the induction of spermidinespermine N1-acetyltransferase using a specific antiserum. J Biol Chem 1984; 259: 12364-7.
44. Parry L, Balana Fouge R, Pegg AE. Post-transcriptional regulation of the content of spermidine/spemine N1-acetyltransferase by N1N12-bis(ethyl)spermine. Biochem J 1995; 305: 451-8.
45. Vujcic S, Liang P, Diegelman P, Kramer DL, Porter CW. Genomic identification and biochemical characterization of the mammalian polyamine oxidase involved in polyamine back-conversion. Biochem J 2003; 370: 19-28.
46. Hölttä E. Oxidation of spermidine and spermine in rat liver: purification and properties of polyamine oxidase. Biochemistry 1977; 16: 91-100.
47. Wang Y, Devereux W, Woster PM, et al. Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res 2001; 61: 5370-3.
48. Adachi MS, Juarez PR, Fitzpatrick PF. Mechanistic studies of human spermine oxidase: kinetic mechanism and pH effects. Biochemistry 2010; 49: 386-92.
49. Tavladoraki P, Cervelli M, Antonangeli F, et al. Probing mammalian spermine oxidase enzyme-substrate complex through molecular modeling, site-directed mutagenesis and biochemical characterization. Amino Acids 2011; 40: 1115-26.
50. Goodwin AC, Destefano Shields CE, Wu S, et al. Polyamine catabolism contributes to enterotoxigenic Bacteroides fragilisinduced colon tumorigenesis. Proc Natl Acad Sci U S A 2011; 108: 15354-9.
51. Seiler N. Catabolism of polyamines. Amino Acids 2004; 26: 217-33.
52. Seiler N, Bolkenius FN, Rennert OM. Interconversion, catabolism and elimination of the polyamines. Med Biol 1981; 59: 334-46.
53. Gahl WA, Pitot HC. Polyamine degradation in foetal and adult bovine serum. Biochem J 1982; 202: 603-11.
54. Seiler N, Bolkenius FN, Knodgen B. The influence of catabolic reactions on polyamine excretion. Biochem J 1985; 225: 219-26.
55. Subirana JA, Soler-Lopez M. Cations as hydrogen bond donors: a view of electrostatic interactions in DNA. Annu Rev Biophys Biomol Struct 2003; 32: 27-45.
56. Luscombe NM, Laskowski RA, Thornton JM. Amino acid-base interactions: a three-dimensional analysis of protein-DNA interactions at an atomic level. Nucleic Acids Res 2001; 29: 2860-74.
57. Marx KA, Reynolds TC. Ion competition and micrococcal nuclease digestion studies of spermidine-condensed calf thymus DNA. Evidence for torus organization by circumferential DNA wrapping. Biochim Biophys Acta 1983; 741: 279-87.
58. Pegg AE, Nagarajan S, Naficy S, Ganem B. Role of unsaturated derivatives of spermidine as substrates for spermine synthase and in supporting growth of SV-3T3 cells. Biochem J 1991; 274: 167-71.
59. Igarashi K, Kashiwagi K, Fukuchi J-I, et al. Spermine-like functions of N1, N12-bis(ethyl)spermine: stimulation of protein synthesis and cell growth and inhibition of gastric ulceration. Biochem Biophys Res Commun 1990; 172: 715-20.
60. Basu HS, Feuerstein BG, Denn DF, et al. Correlation between the effects of polyamine analogues on DNA conformation and cell growth. Cancer Res 1989; 49: 5591-7.
61. Rouzina I, Bloomfield VA. DNA bending by small, mobile multivalent cations. Biophys J 1998; 74: 3152-64.
62. Sundaresan N, Thomas T, Thomas TJ, Pillai CKS. Investigations on the spermine provoked liquid crystalline phase behavior of high molecular weight DNA in the presence of alkali and alkaline earth metal ions. Polym Chem 2011; 2: 2835-41.
63. Pegg AE. The role of polyamine depletion and accumulation of decarboxylated S-adenosyl-methionine in the inhibition of growth of SV-3T3 cells treated with alpha-difluoromethylornithine. Biochem J 1984; 224: 29-38.
64. Hyvönen MT, Keinänen TA, Khomutov M, et al. The use of novel C-methylated spermidine derivatives to investigate the regulation of polyamine metabolism. J Med Chem 2011; 54: 4611-8.
65. Weisell J, Hyvönen MT, Häkkinen MR, et al. Synthesis and biological characterization of novel charge-deficient spermine analogues. J Med Chem 2010; 53: 5738-48.
66. Feuerstein BG, Williams LD, Basu HS, Marton LJ. Implications and concepts of polyamine-nucleic acid interactions. J Cell Biochem 1991; 46: 37-47.
67. Li CH, Ohn T, Ivanov P, Tisdale S, Anderson P. eIF5A promotes translation elongation, polysome disassembly and stress granule assembly. PLoS One 2010; 5: e9942.
68. Hetrick B, Khade PK, Lee K, et al. Polyamines accelerate codon recognition by transfer RNAs on the ribosome. Biochemistry 2010; 49: 7179-89.
69. Libby PR, Bergeron RJ, Porter CW. Structure-function correlations of polyamine analog-induced increases in spermidine/spermine acetyltransferase activity. Biochem Pharmacol 1989; 38: 1435-42.
70. Mitchell JL, Leyser A, Holtorff MS, et al. Antizyme induction by polyamine analogues as a factor of cell growth inhibition. Biochem J 2002; 366: 663-71.
71. Porter CW, Ganis B, Libby PR, Bergeron RJ. Correlations between polyamine analogue-induced increases in spermidine/spermine N1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res 1991; 51: 3715-20.
72. Bergeron RJ, McManis JS, Liu CZ, et al. Antiproliferative properties of polyamine analogues: a structure-activity study. J Med Chem 1994; 37: 3464-76.
73. Kashiwagi K, Williams K, Igarashi K. Anthraquinone polyamines: novel channel blockers of N-methyl-D-aspartate receptors. Amino Acids 2007; 33: 299-304.
74. Pearson WL, Nichols CG. Block of the Kir2. 1 channel pore by alkylamine analogues of endogenous polyamines. J Gen Physiol 1998; 112: 351-63.
75. Williams K. Interactions of polyamines with ion channels. Biochem J 1997; 325: 289-97.
76. Bergeron RJ, Weimar WR, Wu Q, Feng Y, McManis JS. Polyamine analogue regulation of NMDA MK-801 binding: a structure-activity study. J Med Chem 1996; 39: 5257-66.
77. Hyvönen MT, Keinänen TA, Cerrada-Gimenez M, et al. Role of hypusinated eukaryotic translation initiation factor 5A in polyamine depletion-induced cytostasis. J Biol Chem 2007; 282: 34700-6.
78. Howard MT, Shirts BH, Zhou J, et al. Cell culture analysis of the regulatory frameshift event required for the expression of mammalian antizymes. Genes Cells 2001; 6: 931-41.
79. Law GL, Raney A, Heusner C, Morris DR. Polyamine regulation of ribosome pausing at the upstream open reading frame of Sadenosylmethionine decarboxylase. J Biol Chem 2001; 276: 38036-43.
80. Gugliucci A. Polyamines as clinical laboratory tools. Clin Chim Acta 2004; 344: 23-35.
81. Kramer DL, Diegelman P, Jell J, et al. Polyamine acetylation modulates polyamine metabolic flux, a prelude to broader metabolic consequences. J Biol Chem 2008; 283: 4241-51.
82. Pirinen E, Kuulasmaa T, Pietilä M, et al. Enhanced polyamine catabolism alters homeostatic control of white adipose tissue, and energy, and glucose metabolism. Mol Cell Biol 2007; 27: 4953-67.
83. Hyvönen MT, Merentie M, Uimari A, et al. Mechanisms of polyamine catabolism-induced acute pancreatitis. Biochem Soc Trans 2007: 35: 326-30.
84. Babbar N, Murray-Stewart T, Casero RA, Jr. Inflammation and polyamine catabolism: the good, the bad and the ugly. Biochem Soc Trans 2007; 35: 300-4.
85. Chaturvedi R, de Sablet T, Peek R, Wilson K. Spermine oxidase, a polyamine catabolic enzyme that links Helicobacter pylori CagA and gastric cancer risk. Gut Microbes 2012; 3: 48-56.
86. Tanel A, Averill-Bates DA. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta 2005; 1743: 255-67.
87. Finkelstein JD. Metabolic regulatory properties of S-adenosylmethionine and S-adenosylhomocysteine. Clin Chem Lab Med 2007; 45: 1694-9.
88. Savarin P, Barbet A, Delga S, et al. A central role for polyamines in microtubule assembly in cells. Biochem J 2010; 430: 151-9.
89. Chan YH, Marshall WF. How cells know the size of their organelles. Science 2012; 337: 1186-9.
90. Parkkinen JJ, Lammi MJ, Ågren U, et al. Polyamine-dependent alterations in the structure of microfilaments, Golgi apparatus, endoplasmic reticulum, and proteoglycan synthesis in BHK cells. J Cell Biochem 1997; 66: 165-74.
91. Kucharzewska P, Welch JE, Svensson KJ, Belting M. Ornithine decarboxylase and extracellular polyamines regulate microvascular sprouting and actin cytoskeleton dynamics in endothelial cells. Exp Cell Res 2010; 316: 2683-91.
92. Raina A, Jänne J. Physiology of the natural polyamines putrescine, spermidine and spermine. Med Biol 1975; 53: 121-47.
93. Hölttä E, Jänne J, Hovi T. Suppression of the formation of polyamines and macromolecules by DL-alpha-difluoromethylornithine and methylglyoxal bis(guanylhydrazone) in phytohaemagglutinin-activated human lymphocytes. Biochem J 1979; 178: 109-17.
94. Kanerva K, Makitie LT, Back N, Andersson LC. Ornithine decarboxylase antizyme inhibitor 2 regulates intracellular vesicle trafficking. Exp Cell Res 2010; 316: 1896-906.
95. Park MH, Nishimura K, Zanelli CF, Valentini SR. Functional significance of eIF5A and its hypusine modification in eukaryotes. Amino Acids 2010; 38: 491-500.
96. Xu A, Jao DL, Chen KY. Identification of mRNA that binds to eukaryotic initiation factor 5A by affinity co-purification and differential display. Biochem J 2004; 384: 585-90.
97. Kang HA, Hershey JW. Effect of initiation factor eIF-5A depletion on protein synthesis and proliferation of Saccharomyces cerevisiae. J Biol Chem 1994; 269: 3934-40.
98. Maier B, Ogihara T, Trace AP, et al. The unique hypusine modification of eIF5A promotes islet beta cell inflammation and dysfunction in mice. J Clin Invest 2010; 120: 2156-70.
99. Robbins RD, Tersey SA, Ogihara T, et al. Inhibition of deoxyhypusine synthase enhances islet {beta} cell function and survival in the setting of endoplasmic reticulum stress and type 2 diabetes. J Biol Chem 2010; 285: 39943-52.
100. Maier B, Tersey SA, Mirmira RG. Hypusine: a new target for therapeutic intervention in diabetic inflammation. Discov Med 2010; 10: 18-23.
101. Eisenberg T, Knauer H, Schauer A, et al. Induction of autophagy by spermidine promotes longevity. Nat Cell Biol 2009; 11: 1305-14.
102. Ganley IG, Wong PM, Jiang X. Thapsigargin distinguishes membrane fusion in the late stages of endocytosis and autophagy. Autophagy 2011; 7: 1397-9.
103. Ganley IG, Wong PM, Gammoh N, Jiang X. Distinct autophagosomal-lysosomal fusion mechanism revealed by thapsigargin-induced autophagy arrest. Mol Cell 2011; 42: 731-43.
104. Morselli E, Marino G, Bennetzen MV, et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol 2011; 192: 615-29.
105. Marino G, Morselli E, Bennetzen MV, et al. Longevity-relevant regulation of autophagy at the level of the acetylproteome. Autophagy 2011; 7: 647-9.
106. Igarashi K, Kashiwagi K. Characteristics of cellular polyamine transport in prokaryotes and eukaryotes. Plant Physiol Biochem 2010; 48: 506-12.
107. Poulin R, Casero RA, Soulet D. Recent advances in the molecular biology of metazoan polyamine transport. Amino Acids 2012; 42: 711-23.
108. Hoshino K, Momiyama E, Yoshida K, et al. Polyamine transport by mammalian cells and mitochondria: role of antizyme and glycosaminoglycans. J Biol Chem 2005; 280: 42801-8.
109. Gandre S, Bercovich Z, Kahana C. Mitochondrial localization of antizyme is determined by context-dependent alternative utilization of two AUG initiation codons. Mitochondrion 2003; 2: 245-56.
110. Battaglia V, Tibaldi E, Grancara S, et al. Effect of peroxides on spermine transport in rat brain and liver mitochondria. Amino Acids 2012; 42: 741-9.
111. Salvi M, Toninello A. Effects of polyamines on mitochondrial Ca(2+) transport. Biochim Biophys Acta 2004; 1661: 113-24.
112. Raffaello A, De Stefani D, Rizzuto R. The mitochondrial Ca(2+) uniporter. Cell Calcium 2012; 52: 16-21.
113. Grancara S, Battaglia V, Martinis P, et al. Mitochondrial oxidative stress induced by Ca2+ and monoamines: different behaviour of liver and brain mitochondria in undergoing permeability transition. Amino Acids 2012; 42: 751-9.
114. Ha HC, Sirisoma NS, Kuppusamy P, et al. The natural polyamine spermine functions directly as a free radical scavenger. Proc Natl Acad Sci USA 1998; 95: 11140-45.
115. Rhee HJ, Kim EJ, Lee JK. Physiological polyamines: simple primordial stress molecules. J Cell Mol Med 2007; 11: 685-703.
116. Kimes BW, Morris DR. Inhibition of nucleic acid and protein synthesis in Escherichia coli by oxidized polyamines and acrolein. Biochim Biophys Acta 1971; 228: 235-44.
117. Bachrach U. Antiviral activity of oxidized polyamines. Amino Acids 2007; 33: 267-72.
118. Digenis GA, Hawi AA, Yip H, Layton WJ. Detection of tetrafluoroputrescine in RBCs by fluorine-19 nuclear magnetic resonance spectroscopy. Life Sci 1986; 38: 2307-9.
119. Hwang DR, Jerabek PA, Kadmon D, et al. 2-[18F]fluoroputrescine: preparation, biodistribution, and mechanism of defluorination. Int J Rad Appl Instrum A 1986; 37: 607-12.
120. Keinänen TA, Järvinen A, Uimari A, et al. Alpha-methylated polyamines as potential drugs and experimental tools in enzymology. Mini Rev Med Chem 2007; 7: 813-20.
121. Dezeure F, Sarhan S, Seiler N. Chain-fluorinated polyamines as tumor markers-IV. Comparison of 2-fluoroputrescine and 2, 2-difluoro-putrescine as substrates of spermidine synthase in vitro and in vivo. Int J Biochem 1988; 20: 1299-312.
122. Frassineti C, Alderighi L, Gans P, et al. Determination of protonation constants of some fluorinated polyamines by means of 13C NMR data processed by the new computer program HypNMR2000. Protonation sequence in polyamines. Anal Bioanal Chem 2003; 376: 1041-52.
123. Baillon JG, Mamont PS, Wagner J, Gerhart F, Lux P. Fluorinated analogues of spermidine as substrates of spermine synthase. Eur J Biochem 1988; 176: 237-42.
124. Sarhan S, Knodgen B, Gerhart F, Seiler N. Chain-fluorinated polyamines as tumor markers-I. In vivo transformation of 2, 2-difluoroputrescine into 6, 6-difluorospermidine and 6, 6-difluorospermine. Int J Biochem 1987; 19: 843-52.
125. Kramer D, Stanek J, Diegelman P, et al. Use of 4-fluoro-Lornithine to monitor metabolic flux through the polyamine biosynthetic pathway. Biochem Pharmacol 1995; 50: 1433-43.
126. Dezeure F, Gerhart F, Seiler N. Activation of rat liver Sadenosylmethionine decarboxylase by putrescine and 2-substituted 1, 4,-butanediamines. Int J Biochem 1989; 21: 889-99.
127. Cerrada-Gimenez M, Häkkinen MR, Vepsäläinen J, et al. Polyamine flux analysis by determination of heavy isotope incorporation from (13)C, (15)N-enriched amino acids into polyamines by LC-MS/MS. Amino Acids 2012; 42: 451-60.
128. Seiler N, Sarhan S, Knödgen B, Gerhart F. Chain-fluorinated polyamines as tumor markers. II. Metabolic aspects in normal tissues. J Cancer Res Clin Oncol 1988; 114: 71-80.
129. Eloranta TO, Khomutov AR, Khomutov RM, Hyvönen T. Aminooxy analogues of spermidine as inhibitors of spermine synthase and substrates of hepatic polyamine acetylating activity. J Biochem 1990; 108: 593-8.
130. Jakus J, Wolff EC, Park MH, Folk JE. Features of the spermidinebinding site of deoxyhypusine synthase as derived from inhibition studies. J Biol Chem 1993; 268: 13151-59.
131. Park JH, Wolff EC, Folk JE, Park MH. Reversal of the deoxyhypusine synthesis reaction. Generation of spermidine or homospermidine from deoxyhypusine by deoxyhypusine synthase. J Biol Chem 2003; 278: 32683-91.
132. Bollinger JM, Kwon DS, Huisman GW, Kolter R, Walsh CT. Glutathionylspermidine metabolism in Escherichia coli. J Biol Chem 1995; 270: 14031-41.
133. Basu HS, Schwietert HCA, Feuerstein BG, Marton LJ. Effects of variation in the structure of spermine on the association with DNA and the induction of DNA conformational changes. Biochem J 1990; 269: 329-34.
134. Bencini A, Bianchi A, Garcia-España E, Micheloni M, Ramirez JA. Proton coordination by polyamine compounds in aqueous solution. Coord Chem Rev 1999; 188: 97-156.
135. Bertsch CR, Fernelius WC, Block BP. A Thermodynamic Study of Some Complexes of Metal Ions with Polyamines. J Phys Chem 1958; 62: 444-50.
136. Weisell J, Hyvönen MT, Vepsäläinen J, et al. Novel isosteric charge-deficient spermine analogue-1, 12-diamino-3, 6, 9-triazadodecane: synthesis, pK(a) measurement and biological activity. Amino Acids 2010; 38: 501-7.
137. Weisell J, Vepsäläinen J, Peräkylä M. Tautomeric populations of the charged species of 1, 12-diamino-3, 6, 9-triazadodecane (SpmTrien) studied with computer simulations and cluster expansions. J Phys Org. Chem 2013; 26: 360-6.
138. Weisell JM. Structure and function of charge deficient polyamines; The latest generation of isosteric charge deficient spermine analogues. Publications of the University of Eastern Finland: Kuopio, Finland 2012.
139. McCormack SA, Zimmerman BJ, Israel M, Blanner P, Johnson LR. Structural requirements of analogues of polyamines for migration and growth of IEC-6 cells. Mol Pharmacol 1995; 48: 724-9.
140. Walshe JM. Management of penicillamine nephropathy in Wilson's disease: a new chelating agent. Lancet 1969; 2: 1401-2.
141. Cooper GJ. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease. Drugs 2011; 71: 1281-320.
142. Cooper GJ, Young AA, Gamble GD, et al. A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study. Diabetologia 2009; 52: 715-22.
143. Yin F, Liu J, Peng X. Triethylene tetraamine: a novel telomerase inhibitor. Bioorg Med Chem Lett 2003; 13: 3923-6.
144. Lu J, Poppitt SD, Othman AA, et al. Pharmacokinetics, pharmacodynamics, and metabolism of triethylenetetramine in healthy human participants: an open-label trial. J Clin Pharmacol 2010; 50: 647-58.
145. Hyvönen MT, Weisell J, Khomutov A, et al. Metabolism of triethylenetetramine and 1, 12-diamino-3, 6, 9-triazadodecane by the spermidine/spermine-N1-acetyltransferase and thialysine acetyltransferase. Drug Metab Dispos 2013; 41: 30-2.
146. Peled T, Landau E, Mandel J, et al. Linear polyamine copper chelator tetraethylenepentamine augments long-term ex vivo expansion of cord blood-derived CD34+ cells and increases their engraftment potential in NOD/SCID mice. Exp Hematol 2004; 32: 547-55.
147. de Lima M, McMannis J, Gee A, et al. Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial. Bone Marrow Transplant 2008; 41: 771-8.
148. Cerrada-Gimenez M, Weisell J, Hyvönen MT, et al. Complex Nacetylation of triethylenetetramine. Drug Metab Dispos 2011; 39: 2242-9.
149. Tisato F, Marzano C, Porchia M, Pellei M, Santini C. Copper in diseases and treatments, and copper-based anticancer strategies. Med Res Rev 2010; 30: 708-49.
150. Nurchi VM, Crisponi G, Crespo-Alonso M, et al. Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono-and di-acetyl metabolites. Dalton Trans 2012.
151. Lu J, Chan YK, Gamble GD, et al. Triethylenetetramine and metabolites: levels in relation to copper and zinc excretion in urine of healthy volunteers and type 2 diabetic patients. Drug Metab Dispos 2007; 35: 221-7.
152. Kodama H, Murata Y, Iitsuka T, Abe T. Metabolism of administered triethylene tetramine dihydrochloride in humans. Life Sci 1997; 61: 899-907.
153. Metcalf BW, Bey P, Danzin C, et al. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E. C. 4. 1. 1. 17) by substrate and product analogues. J Am. Chem. Soc 1978; 100: 2551-53.
154. Seiler N. Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 1. Selective enzyme inhibitors. Curr Drug Targets 2003; 4: 537-64.
155. Raul F. Revival of 2-(difluoromethyl)ornithine (DFMO), an inhibitor of polyamine biosynthesis, as a cancer chemopreventive agent. Biochem Soc Trans 2007; 35: 353-5.
156. Heby O, Persson L, Rentala M. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis. Amino Acids 2007; 33: 359-66.
157. Kennedy PG. Human African trypanosomiasis-neurological aspects. J Neurol 2006; 253: 411-6.
158. Wolf JE, Jr., Shander D, Huber F, et al. Randomized, double-blind clinical evaluation of the efficacy and safety of topical eflornithine HCl 13. 9% cream in the treatment of women with facial hair. Int J Dermatol 2007; 46: 94-8.
159. Brodell LA, Mercurio MG. Hirsutism: Diagnosis and management. Gend Med 2010; 7: 79-87.
160. Babbar N, Gerner EW. Targeting polyamines and inflammation for cancer prevention. Recent Results Cancer Res 2011; 188: 49-64.
161. Gerner EW. Impact of dietary amino acids and polyamines on intestinal carcinogenesis and chemoprevention in mouse models. Biochem Soc Trans 2007; 35: 322-5.
162. Raj KP, Zell JA, Rock CL, et al. Role of dietary polyamines in a phase III clinical trial of difluoromethylornithine (DFMO) and sulindac for prevention of sporadic colorectal adenomas. Br J Cancer 2013; 108: 512-8.
163. Hessels J, Kingma AW, Ferwerda H, et al. Microbial flora in the gastrointestinal tract abolishes cytostatic effects of alphadifluoromethylornithine in vivo. Int J Cancer 1989; 43: 1155-64.
164. Quemener V, Blanchard Y, Chamaillard L, et al. Polyamine deprivation: a new tool in cancer treatment. Anticancer Res 1994; 14: 443-8.
165. Harik SI, Snyder SH. Ornithine decarboxylase: inhibition by alphahydrazino-ornithine. Biochim Biophys Acta 1973; 327: 501-9.
166. Inoue H, Kato Y, Takigawa M, Adachi K, Takeda Y. Effect of DLalpha-hydrazino-delta-aminovaleric acid, an inhibitor of ornithine decarboxylase, on polyamine metabolism in isoproterenolstimulated mouse parotid glands. J Biochem 1975; 77: 879-93.
167. Rahiala E-L, Kekomäki M, Jänne J, Raina A, Räihä NCR. Inhibition of pyridoxal enzymes by L-canaline. Biochim Biophys Acta 1971; 227: 337-43.
168. Khomutov RM, Denisova GF, Khomutov AR, et al. Aminooxypropylamine as an effective inhibitor of ornithine decarboxylase in vitro and in vivo. Bioorgan Khim 1985; 11: 1574-76.
169. Poulin R, Secrist III JA, Pegg AE. Effect of 1-amino-oxy-3-aminopropane on polyamine metabolism and growth of L1210 cells. Biochem J 1989; 263: 215-21.
170. Obenrader MF, Prouty WF. Detection of multiple forms of rat liver ornithine decarboxylase. J Biol Chem 1977; 252: 2860-65.
171. Khomutov RM, Hyvönen T, Karvonen E, et al. 1-Aminooxy-3-aminopropane, a new and potent inhibitor of polyamine biosynthesis that inhibits ornithine decarboxylase, adenosylmethionine decarboxylase and spermidine synthase. Biochem Biophys Res Commun 1985; 130: 596-602.
172. Singh S, Mukherjee A, Khomutov AR, et al. Antileishmanial effect of 3-aminooxy-1-aminopropane is due to polyamine depletion. Antimicrob Agents Chemother 2007; 51: 528-34.
173. Dufe VT, Ingner D, Heby O, et al. A structural insight into the inhibition of human and Leishmania donovani ornithine decarboxylases by 1-amino-oxy-3-aminopropane. Biochem J 2007; 405: 261-8.
174. Das Gupta R, Krause-Ihle T, Bergmann B, et al. 3-Aminooxy-1-aminopropane and derivatives have an antiproliferative effect on cultured Plasmodium falciparum by decreasing intracellular polyamine concentrations. Antimicrob Agents Chemother 2005; 49: 2857-64.
175. Stanek J, Frei J, Mett H, Schneider P, Regenass U. 2-substituted 3-(aminooxy) propanamines as inhibitors of ornithine decarboxylase: synthesis and biological activity. J Med Chem 1992; 35: 1339-44.
176. Birkholtz L, Joubert F, Neitz AW, Louw AI. Comparative properties of a three-dimensional model of Plasmodium falciparum ornithine decarboxylase. Proteins 2003; 50: 464-73.
177. Dirksen A, Dawson PE. Rapid oxime and hydrazone ligations with aromatic aldehydes for biomolecular labeling. Bioconjug Chem 2008; 19: 2543-8.
178. Cordes EH, Jencks WP. Semicarbazone formation from pyridoxal, pyridoxal phosphate, and their Schiff bases. Biochemistry 1962; 1: 773-8.
179. Cordes EH, Jencks WP. Nucleophilic catalysis of semicarbazone formation by anilines. J Am Chem Soc 1962; 84: 826-31.
180. Artamonova EY, Khomutov AR, Zavalova LL, Khomutov RM. Irreversible inhibition of S-adenosylmethionine decarboxylase by hydroxylamine-containing analogues of decarboxylated Sadenosylmethionine. Bioorgan Khim 1986; 12: 206-12.
181. Krause T, Luersen K, Wrenger C, et al. The ornithine decarboxylase domain of the bifunctional ornithine decarboxylase/Sadenosylmethionine decarboxylase of Plasmodium falciparum: recombinant expression and catalytic properties of two different constructs. Biochem J 2000; 352: 287-92.
182. Sashchenko LP, Severin ES, Khomutov RM. [On the inhibition of L-glutamic acid decarboxylase by derivatives of hydroxylamine and related compounds]. Biokhimiia 1968; 33: 142-7.
183. Baxter CF, Roberts E. Elevation of gamma-aminobutyric acid in brain: selective inhibition of gamma-aminobutyric-alphaketoglutaric acid transaminase. J Biol Chem 1961; 236: 3287-94.
184. Delbaere LT, Kallen J, Markovic-Housley Z, et al. Complexes of aspartate aminotransferase with hydroxylamine derivatives: spectral studies in solution and in the crystalline state. Biochimie 1989; 71: 449-59.
185. Capitani G, Eliot AC, Gut H, et al. Structure of 1-aminocyclopropane-1-carboxylate synthase in complex with an amino-oxy analogue of the substrate: implications for substrate binding. Biochim Biophys Acta 2003; 1647: 55-60.
186. Gabibov AG, Shuster AM, Khomutov AR, et al. Cystathionase: catalytic activity of products of expression of cDNA fragments. Specific inhibition of native enzyme and fusion-protein by substrate-like O-substituted hydroxylamine. Dokl Akad Nauk Russian 1996; 350: 405-7.
187. Pegg AE, Jones DB, Secrist III JA. Effect of inhibitors of Sadenosylmethionine decarboxylase on polyamine content and growth of L1210 cells. Biochemistry 1988; 27: 1408-15.
188. McCloskey DE, Bale S, Secrist JA, 3rd, et al. New insights into the design of inhibitors of human S-adenosylmethionine decarboxylase: studies of adenine C8 substitution in structural analogues of Sadenosylmethionine. J Med Chem 2009; 52: 1388-407.
189. Markovic-Housley Z, Schirmer T, Hohenester E, et al. Crystal structures and solution studies of oxime adducts of mitochondrial aspartate aminotransferase. Eur J Biochem 1996; 236: 1025-32.
190. Liu W, Peterson PE, Carter RJ, et al. Crystal structures of unbound and aminooxyacetate-bound Escherichia coli gammaaminobutyrate aminotransferase. Biochemistry 2004; 43: 10896-905.
191. Revtovich SV, Morozova EA, Khurs EN, et al. Three-dimensional structures of noncovalent complexes of Citrobacter freundii methionine gamma-lyase with substrates. Biochemistry (Mosc) 2011; 76: 564-70.
192. Haider N, Eschbach ML, Dias Sde S, et al. The spermidine synthase of the malaria parasite Plasmodium falciparum: molecular and biochemical characterisation of the polyamine synthesis enzyme. Mol Biochem Parasitol 2005; 142: 224-36.
193. Hyvönen T, Khomutov AR, Khomutov RM, Lapinjoki S, Eloranta TO. Uptake of 3H-labeled 1-aminooxy-3-aminopropane by baby hamster kidney cells. J Biochem 1990; 107: 817-20.
194. Keinänen TA, Hyvönen T, Pankaskie MC, Vepsäläinen JJ, Eloranta TO. Derivatives of 1-aminooxy-3-aminopropane as polyamine antimetabolites: Stability and effects on BHK21/C13 cells. J Biochem 1994; 116: 1056-62.
195. Hyvönen T, Keinänen TA, Khomutov AR, Khomutov RM, Eloranta TO. Monitoring of the uptake and metabolism of aminooxy analogues of polyamines in cultured cells by highperformance liquid chromatography. J Chromatogr 1992; 574: 17-21.
196. Turchanowa L, Shvetsov AS, Demin AV, et al. Insufficiently charged isosteric analogue of spermine: interaction with polyamine uptake, and effect on Caco-2 cell growth. Biochem Pharmacol 2002; 64: 649-55.
197. Khomutov AR, Shvetsov AS, Vepsäläinen J, et al. New Aminooxy Analogs of Biogenic Polyamines. Bioorgan Khim 1996; 22: 557-9.
198. Persson L, Khomutov AR, Khomutov RM. Feedback regulation of S-adenosylmethionine synthesis. Biochem J 1989; 257: 929-31.
199. Hyvönen T, Alakuijala L, Andersson L, et al. 1-Aminooxy-3-aminopropane reversibly prevents the proliferation of cultured Baby Hamster Kidney cells by interfering with polyamine synthesis. J Biol Chem 1988; 263: 11138-44.
200. Mett H, Stanek J, Lopez-Ballester JA, et al. Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analogues. Cancer Chemother Pharmacol 1993; 32: 39-45.
201. Milovic V, Turchanowa L, Khomutov AR, et al. Hydroxylaminecontaining inhibitors of polyamine biosynthesis and impairment of colon cancer cell growth. Biochem Pharmacol 2001; 61: 199-206.
202. Frei J, Stanek J, inventors;, Giba-Geigy Corporation T, NY. assignee. Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives. United States Patent US005610195A 1997 Mar.
203. Polyakov VA, Nelen MI, Nazarpac-Kandlousy N, Ryabov AD, Eliseev AV. Imine exchange in O-aryl and O-alkyl oximes as a base reaction for aqueous "dynamic" combinatorial libraries. Akinetic and thermodynamic study. J Phys Org Chem 1999; 12: 357-63.
204. Belowich ME, Stoddart JF. Dynamic imine chemistry. Chem Soc Rev 2012; 41: 2003-24.
205. Birkholtz LM, Williams M, Niemand J, et al. Polyamine homoeostasis as a drug target in pathogenic protozoa: peculiarities and possibilities. Biochem J 2011; 438: 229-44.
206. Singh S, Jhingran A, Sharma A, et al. Novel agmatine analogue, gamma-guanidinooxypropylamine (GAPA) efficiently inhibits proliferation of Leishmania donovani by depletion of intracellular polyamine levels. Biochem Biophys Res Commun 2008; 375: 168-72.
207. Khomutov MA, Mandal S, Weisell J, et al. Novel convenient synthesis of biologically active esters of hydroxylamine. Amino Acids 2010; 38: 509-17.
208. Rajam MV, Weinstein LH, Galston AW. Prevention of a plant disease by specific inhibition of fungal polyamine biosynthesis. Proc Natl Acad Sci USA 1985; 82: 6874-78.
209. Khomutov AR, Dzavakhia VG, Voinova TM, Ermolinsky BS, Khomutov RM. Aminooxy analogue of putrescine inhibits polyketide biosynthetic pathway of natural products. Bioorgan Khim 1989; 15: 707-9.
210. Khomutov AR, Khomutov RM. Synthesis of Putrescine and Spermidine Aminooxyanalogues. Bioorgan Khim 1989; 15: 698-703.
211. Nedospasov AA, Khomutov RM. Use of N-protected aminoalkoxyamines in synthesis of aminooxy adsorbents using BrCN. Izv. Akad. Nauk SSSR, Ser. Khim 1978: 2397-400.
212. Lee YB, Park MH, Folk JE. Diamine and triamine analogs and derivatives as inhibitors of deoxyhypusine synthase: synthesis and biological activity. J Med Chem 1995; 38: 3053-61.
213. Lin PKT, Maguire NM, Brown DM. Synthesis of novel oxaisosteres of spermidine and spermine. Tetrahedron Lett 1994; 35: 3605-8.
214. Khomutov AR, Vepsäläinen JJ, Shvetsov AS, et al. Synthesis of hydroxylamine analogues of polyamines. Tetrahedron 1996; 52: 13751-66.
215. Khomutov AR, Simonyan AR, Vepsäläinen J, et al. New oxaanalogues of spermine. Russian J Bioorganic Chem 2005; 31: 189-95.
216. Simonian A, Khomutov A, Hyvönen T, et al. Novel CoApolyamine conjugates for effective inhibition of spermine/spermidine-N-1-acetyltransferase. Nucleosides Nucleotides Nucleic Acids 2007; 26: 1245-48.
217. Erwin BG, Persson L, Pegg AE. Differential inhibition of histone and polyamine acetylases by multisubstrate analogues. Biochemistry 1984; 23: 4250-5.
218. Järvinen AJ, Cerrada-Gimenez M, Grigorenko NA, et al. Alpha-Methyl polyamines: Efficient synthesis and tolerance studies in vivo and in vitro. First evidence for dormant stereospecificity of polyamine oxidase. J Med Chem 2006; 49: 399-406.
219. Hyvönen T, Keinänen TA, Khomutov AR, Khomutov RM, Eloranta TO. Aminooxy analogues of spermidine evidence the divergent roles of the charged amino nitrogens in the cellular physiology of spermidine. Life Sci 1995; 56: 349-60.
220. Vujcic S, Diegelman P, Bacchi CJ, Kramer DL, Porter CW. Identification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin. Biochem J 2002; 367: 665-75.
221. Wang Y, Murray-Stewart T, Devereux W, et al. Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem Biophys Res Commun 2003; 304: 605-11.
222. Deng H, Bloomfield VA, Benevides JM, Jr GJ. Structural basis of polyamine-DNA recognition: spermidine and spermine interactions with genomic B-DNAs of different GC content probed by raman spectroscopy. Nucleic Acids Res 2000; 28: 3379-85.
223. Hasan R, Moinuddin KA, Ali R. Polyamine induced Zconformation of native calf thymus DNA. FEBS Lett 1995; 368: 27-30.
224. Jain S, Zon G, Sundaralingam M. Base only binding of spermine in the deep groove of the A-DNA octamer d(GTGTACAC). Biochemistry 1989; 28: 2360-4.
225. Bancroft D, Williams LD, Rich A, Egli M. The low-temperature crystal structure of the pure-spermine form of Z-DNA reveals binding of a spermine moleculse in the minor groove. Biochemistry 1994; 33: 1073-86.
226. Feuerstein BG, Pattabiraman N, Marton LJ. Molecular dynamics of spermine-DNA interactions: sequence specificity and DNA bending for a simple ligand. Nucleic Acids Res 1989; 17: 6883-92.
227. Saminathan M, Antony T, Shirahata A, et al. Ionic and structural specificity effects of natural and synthetic polyamines on the aggregation and resolubilization of single-, double-, and triplestranded DNA. Biochemistry 1999; 38: 3821-30.
228. Ramirez FJ, Thomas TJ, Antony T, Ruiz-Chica J, Thomas T. Effects of aminooxy analogues of biogenic polyamines on aggregation and stability of calf thymus DNA. Biopolymers 2002; 65: 148-57.
229. Khomutov AR, Kritsky AM, Artamonova EY, Khomutov RM. Polyfunctional O-substited hydroxilamines: modification of nucleic acids, analogs of the decarboxylated S-adenosylmethionine. Nucleosides & Nucleotides 1987; 6: 53-56.
230. Kritsky AM, Khomutov AR, Yakovlev DY, et al. Method for the introduction of reactive functional groups via cytidine and or 3'-terminal of the nucleic acids. Nuc Acid Res Symp Ser 1987; 89-92.
231. Adamczyk M, Mattingly PG, Moore JA, Pan Y. Synthesis of a chemiluminescent acridinium hydroxylamine (AHA) for the direct detection of abasic sites in DNA. Org Lett 1999; 1: 779-81.
232. Budowsky EI. The mechanism of the mutagenic action of hydroxylamines. In: Cohn WE, ed. eds., Progress in Nucleic Acids Research and Molecular Biology. Academic Press: New York San Francisco London 1976; pp. 125-88.
233. Adarichev VA, Kalachikov SM, Kiseliova AV, Dymshits GM. Molecular hybridization probes prepared with 4-aminooxybutylamine. Bioconjug Chem 1998; 9: 671-5.
234. Adarichev VA, Vorob'eva NV, Grafodatskii AS, Dymshits GM, Sablina OV. Modification of DNA with 4-aminooxybutylamine as a method for obtaining highly-sensitive hybridization probes. Mapping of the gene for human chorionic somatomammotropin hormone. Mol Biol (Mosk) 1995; 29: 538-45.